Fallout From ‘Nuclear Button鈥 Tweets: Sales Of Anti-Radiation Drug Skyrocket
Orders for potassium iodide reportedly jumped after a Jan. 2 war of words between Trump and North Korea鈥檚 Kim Jong-un.
Drugs
1,061-1,080 of 1,323 results
-
-
Facebook Live: It鈥檚 2018, Can Big Pharma Hold The Line Against Pricing Controls?
In this chat, KHN senior correspondent Jay Hancock discusses how drug-pricing battles could play out this year in D.C., state legislatures and beyond. What do we know about the drug industry鈥檚 agenda to quiet the drumbeat of cost control and transparency proposals? How will they officials target their efforts? Will the battles take place at the state level? Senior editor Stephanie Stapleton moderates.
-
HHS Nominee Vows To Tackle High Drug Costs, Despite His Ties To Industry
Alex M. Azar II, the former president of the U.S. division of Eli Lilly, says the U.S. drug system encourages price increases 鈥 but he intends to work on that problem.
-
Drug Overdose Deaths Soar Nationally But Plateau In Some Western States
Fatalities are climbing in states that have been flooded by the deadly opioid fentanyl, but are remaining flat 鈥 or even falling 鈥 in many Western states, where the drug has not yet been as common as other parts of the country.
-
Grassley Calls For 鈥楥orrective Action鈥 On Abuses In Herpes Vaccine Research
The Republican senator sent out letters to the Food and Drug Administration and HHS demanding an explanation about a rogue herpes vaccine trial.
-
From Retirement To The Front Lines Of Hepatitis C Treatment
This doctor came out of retirement with the goal of treating every patient at high risk for hepatitis C he encounters. The problem is finding them.
-
Readers Have Bones To Pick, From Health System Flaws To Covering Pot Beat
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
-
FDA Chief Says He鈥檚 Open To Rethinking Incentives On Orphan Drugs
The FDA鈥檚 Scott Gottlieb says the agency is focused on the big picture, and he wants to know why pharma churns out drugs for some rare diseases but not for others.
-
Arthritis Drugs Show How U.S. Drug Prices Defy Economics
Drugs that treat rheumatoid arthritis started out costing about $10,000 a year. Ten years later, they list for more than $40,000.
-
Biosimilars, Biologics And New Legal Challenges For RA Treatments
As biosimilar products reach the market and rival more established RA treatments, the players are exploring legal challenges involving antitrust and anti-competitive behavior.
-
Unregulated Herpes Experiments Expose 鈥楤lack Hole鈥 Of Accountability
Controversial research methods by university researcher unlikely to prompt federal response or institutional change, experts say.
-
Arizona Declares Opioid Emergency, But Signals Are Mixed Over Best Response
Arizona is one of a few states that have declared the opioid epidemic a public health emergency. There's no uniformity in what that means from state to state, though, and even within Arizona, there's a wide divergence of opinion on how best to tackle the problem.
-
Drug Industry Spent Millions To Squelch Talk About High Drug Prices
Last year, the pharma industry鈥 biggest trade group raised millions to change the conversation about drug pricing.
By Jay Hancock -
Medicare Fails To Recover Hundreds Of Millions Of Dollars In Lab Overcharges
Genetic testing firms declare bankruptcy and wipe out debt to the federal government.
By Fred Schulte -
Experts Tell Congress How To Cut Drug Prices. We Give You Some Odds.
Some of the nation鈥檚 most influential scientists recommend eight steps to lower drug prices. KHN takes the political temperature and tells you the chances of Congress acting on them.
-
An Overlooked Epidemic: Older Americans Taking Too Many Unneeded Drugs
Researchers estimate that 25 percent of people ages 65 to 69 take at least five prescription drugs to treat chronic conditions. But some doctors are trying to teach others about 鈥渄eprescribing鈥 or systematically discontinuing medicines that are inappropriate, duplicative or unnecessary.
-
Cities, Counties and Schools Sidestep FDA Canadian Drug Crackdown, Saving Millions
Medicines are up to 80 percent cheaper north of the border and overseas, so U.S. localities are greasing a pharmaceutical pipeline that the feds warn is illegal and possibly unsafe.
-
Pace Of U.S. Health Spending Slows In 2016
Dramatic increases in spending that came with the influx of newly insured consumers in 2014 and 2015 appear to be moderating.
-
Stopping Opioid Addiction At One Key Source: The Hospital
Based on research conducted at the University of Michigan鈥檚 medical center, a group of surgeons developed a strategy to help post-surgical patients from misusing or abusing their prescription painkillers.
-
Texans With HIV Cope With Homes And Medicines Ruined By Hurricane Harvey
The hurricane closed pharmacies and clinics for a week or longer. Floodwaters spoiled drugs. People who fled to other states couldn't get their prescriptions filled for HIV medicine.
By Sarah Varney